Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00377702 · ClinicalTrials.gov registry record
Lifetime Risk for Cardiovascular Disease Among Non-White Ethnic Groups
A clinical trial, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 500,000
- Enrollment target
NCT00377702: Completed study, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
NCT00377702 is a clinical trial that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 500,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00377702 has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 500,000 participants
- Enrollment target
Study Summary
Cardiovascular disease (CVD) is one of the leading causes of death in the United States. Currently, there is little information about the lifetime risk of CVD among non-white ethnic groups. This study will analyze data from participants in several ongoing clinical studies to identify the lifetime risk for CVD among various ethnicities.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500,000 participants |
| Start Date | 2006-07 |
| Est. Completion | 2006-07 |
What the finished NCT00377702 record still lists
NCT00377702 is an observational study that tracks outcomes without assigning an intervention. Its 500,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00377702 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00377702 about?
NCT00377702 is a clinical study titled "Lifetime Risk for Cardiovascular Disease Among Non-White Ethnic Groups". Cardiovascular disease (CVD) is one of the leading causes of death in the United States. Currently, there is little information about the lifetime risk of CVD among non-white ethnic groups. This study will analyze data from participants in several ongoing clinical studies to identify the lifetime ri...
What is the current status of trial NCT00377702?
This trial is currently completed. The enrollment target is 500,000 participants. The study started on 2006-07. Estimated completion is 2006-07.
Who is sponsoring clinical trial NCT00377702?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05065060 · 500,000 participants
Parkinson Progression Marker Initiative Online (PPMI Online)
- NCT06017687 · 500,000 participants · NA
Data Collection and Evaluation of OptiBP Under Investigational Use
- NCT06342375 · 425,000 participants · NA
Enrollment Barriers, Procedural Denials, and Loss of Medicaid Coverage
- NCT06934239 · 400,000 participants · Phase 4
A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia